.Pharmacolibrary.Drugs.ATC.L.L02AE02 .Pharmacolibrary.Drugs.ATC.L.L02AE02| name: | Leuprorelin | |
| ATC code: | L02AE02 | route: | subcutaneous |
| compartments: | 2 | |
| dosage: | 1 | mg |
| volume of distribution: | 27 | L |
| clearance: | 8.34 | L/h |
| other parameters in model implementation | ||
Leuprorelin (leuprolide acetate) is a synthetic gonadotropin-releasing hormone (GnRH) agonist, primarily used for the treatment of hormone-responsive cancers such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty. It is approved and widely used in clinical practice today.
Pharmacokinetic parameters reported in adult males with advanced prostate cancer following a single subcutaneous 1 mg dose.